Modeling simple repeat expansion diseases with iPSC technology

被引:12
|
作者
Jaworska, Edyta [1 ]
Kozlowska, Emilia [1 ]
Switonski, Pawel M. [1 ]
Krzyzosiak, Wlodzimierz J. [1 ]
机构
[1] Polish Acad Sci, Inst Bioorgan Chem, Dept Mol Biomed, Noskowskiego 12-14 Str, PL-61704 Poznan, Poland
关键词
Pluripotent cells; TRED; PolyQ diseases; Triplet repeat expansion; Neurodegeneration; Neurons; PLURIPOTENT STEM-CELLS; QUANTITATIVE PROTEOMIC ANALYSIS; AMYOTROPHIC-LATERAL-SCLEROSIS; IN-VITRO DIFFERENTIATION; ADULT HUMAN FIBROBLASTS; FRAGILE-X-SYNDROME; MOTOR-NEURONS; FRONTOTEMPORAL DEMENTIA; FRIEDREICHS-ATAXIA; NEURAL DIFFERENTIATION;
D O I
10.1007/s00018-016-2284-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A number of human genetic disorders, including Huntington's disease, myotonic dystrophy type 1, C9ORF72 form of amyotrophic lateral sclerosis and several spinocerebellar ataxias, are caused by the expansion of various microsatellite sequences in single implicated genes. The neurodegenerative and neuromuscular nature of the repeat expansion disorders considerably limits the access of researchers to appropriate cellular models of these diseases. This limitation, however, can be overcome by the application of induced pluripotent stem cell (iPSC) technology. In this paper, we review the current knowledge on the modeling of repeat expansion diseases with human iPSCs and iPSC-derived cells, focusing on the disease phenotypes recapitulated in these models. In subsequent sections, we provide basic practical knowledge regarding iPSC generation, characterization and differentiation into neurons. We also cover disease modeling in iPSCs, neuronal stem cells and specialized neuronal cultures. Furthermore, we also summarize the therapeutic potential of iPSC technology in repeat expansion diseases.
引用
收藏
页码:4085 / 4100
页数:16
相关论文
共 50 条
  • [21] Modeling neurological diseases using iPSC-derived neural cellsiPSC modeling of neurological diseases
    Li Li
    Jianfei Chao
    Yanhong Shi
    Cell and Tissue Research, 2018, 371 : 143 - 151
  • [22] The Repeat Expansion Diseases: The dark side of DNA repair
    Zhao, Xiao-Nan
    Usdin, Karen
    DNA REPAIR, 2015, 32 : 96 - 105
  • [23] Implications of Poly(A) Tail Processing in Repeat Expansion Diseases
    Joachimiak, Pawel
    Ciesiolka, Adam
    Figura, Grzegorz
    Fiszer, Agnieszka
    CELLS, 2022, 11 (04)
  • [24] An overview of pathogenic mechanisms in some repeat expansion diseases
    Mandel, JL
    NEUROMUSCULAR DISORDERS, 2004, 14 (8-9) : 598 - 598
  • [25] Diseases of Unstable Repeat Expansion: Mechanisms and Common Principles
    Jennifer R. Gatchel
    Huda Y. Zoghbi
    Nature Reviews Genetics, 2005, 6 : 743 - 755
  • [26] Diseases of unstable repeat expansion: Mechanisms and common principles
    Gatchel, JR
    Zoghbi, HY
    NATURE REVIEWS GENETICS, 2005, 6 (10) : 743 - 755
  • [27] Transgenic mice in the study of polyglutamine repeat expansion diseases
    Bates, GP
    Mangiarini, L
    Davies, SW
    BRAIN PATHOLOGY, 1998, 8 (04) : 699 - 714
  • [28] Microsatellite Expansion Diseases: Repeat Toxicity Found in Translation
    Gao, Fen-Biao
    Richter, Joel D.
    NEURON, 2017, 93 (02) : 249 - 251
  • [29] The Role of the Immune System in Triplet Repeat Expansion Diseases
    Olejniczak, Marta
    Urbanek, Martyna O.
    Krzyzosiak, Wlodzimierz J.
    MEDIATORS OF INFLAMMATION, 2015, 2015
  • [30] The use of iPSC technology for modeling Autism Spectrum Disorders
    Russo, Fabiele Baldino
    Brito, Anita
    de Freitas, Ariane Miranda
    Castanha, Andrelissa
    de Freitas, Beatriz C.
    Baleeiro Beltrao-Braga, Patricia Cristina
    NEUROBIOLOGY OF DISEASE, 2019, 130